SCR 80: Frontotemporal Degeneration Awareness Week.
- Session Year: 2025-2026
- House: Senate
- Latest Version Date: 2025-09-09
Current Status:
Passed
(2025-09-09: Chaptered by Secretary of State. Res. Chapter 172, Statutes of 2025.)
Introduced
In Committee
Awaiting First Chamber Vote
Passed First Chamber
In Committee
Awaiting Second Chamber Vote
Passed Second Chamber
Enacted
This measure would declare the week of September 21 to September 28, 2025, inclusive, as Frontotemporal Degeneration Awareness Week.
This measure would declare the week of September 21 to September 28, 2025, inclusive, as Frontotemporal Degeneration Awareness Week.
This measure would proclaim declare the week of September 21 to September 28, 2025, inclusive, as Frontotemporal Degeneration Awareness Week.
This measure would proclaim the week of September 21 to September 28, 2025, inclusive, as Frontotemporal Degeneration Awareness Week.
This measure would proclaim the week of September 21 to September 28, 2025, inclusive, as Frontotemporal Degeneration Awareness Week.
WHEREAS, It is the custom of the Legislature to recognize official weeks that are set aside to increase awareness of serious health conditions that affect the lives of citizens of California; and
WHEREAS, Attendant to that concern and in full accord with its longstanding traditions, it is the sense of the Legislature to memorialize and to proclaim the week of September 21 to September 28, 2025, inclusive, as Frontotemporal Degeneration Awareness Week in California, in conjunction with the observance of World FTD Awareness Week; and
WHEREAS, The Association for Frontotemporal Degeneration (AFTD) reports that Frontotemporal Degeneration (FTD) is a terminal and incurable neurodegenerative disease affecting the frontal and temporal lobes, causing impairments to speech, personality, behavior, and motor skills that constitutes a major public health concern; and
WHEREAS, It takes an average of 3.6 years from the initial symptoms to get an accurate diagnosis of FTD, with an average life expectancy of 7 to 13 years after the initial symptoms; and
WHEREAS, FTD strikes people as young as 21 years of age and as old as 80 years of age, with the largest percentage of those affected being in their 40s to 60s, rendering people in the prime of life unable to work or function normally; and
WHEREAS, FTD imposes average annual costs associated with care and living with the disease that are approximately double those of Alzheimers disease; and
WHEREAS, FTD is identified in the National Plan to Address Alzheimers Disease as a related dementia and included as a priority in the goals and strategies of the plan to achieve the vision of a nation free of Alzheimers disease and related dementias; and
WHEREAS, The California Master Plan for Aging incorporates all 10 recommendations from the Governors Task Force on Alzheimers (Disease) Prevention and Preparedness to help people and families living with Alzheimers disease and related dementia; and
WHEREAS, FTD represents an estimated 5 to 15 percent of all dementia cases and is the most common form of dementia for people under 60 years of age; and
WHEREAS, Approximately 40 percent of people with FTD have a family history of FTD or a related condition such as Amyotrophic Lateral Sclerosis (ALS), with about one-half of those found to have an inherited form accounted for by mutations in the Progranulin, C9orf72, Tau/MAPT and other rarer genes; and
WHEREAS, FTD is often misdiagnosed as a psychiatric problem or other neurodegenerative disease because of the wide range of cognitive and behavioral symptoms and their young onset; and
WHEREAS, FTD often affects a persons ability to express emotions and to show affection and empathy for loved ones; and
WHEREAS, In the behavioral variant of FTD, a persons sense of social graces and appropriate behavior can be lost, and their personality may be significantly changed; and
WHEREAS, Furthermore, in the language variants of FTD (primary progressive aphasia), a person may have trouble producing speech and understanding grammar, lose the meaning of words or become hesitant in their speech, and may eventually become mute; and
WHEREAS, In the movement variants of FTD, a person may experience muscle weakness, falling, loss of balance, difficulty making speech, difficulty swallowing, or choking; and
WHEREAS, While there has never been a global epidemiology study of FTD, it is estimated that more than 60,000 people are affected in the United States today; and
WHEREAS, The AFTD is the leading national organization exclusively focused on the spectrum of FTD disorders with a mission to improve the quality of life of people affected by FTD and drive research to a cure; and
WHEREAS, It is imperative that there be greater awareness of this serious disease, and more must be done to increase activity at the local, state, and national levels; now, therefore, be it
Resolved by the Senate of the State of California, the Assembly thereof concurring, That the Legislature declares the week of September 21 to September 28, 2025, inclusive, as Frontotemporal Degeneration Awareness Week; and be it further
Resolved, That the Secretary of the Senate transmit copies of this resolution to the author for appropriate distribution.
WHEREAS, It is the custom of the Legislature to recognize official weeks that are set aside to increase awareness of serious health conditions that affect the lives of citizens of California; and
WHEREAS, Attendant to that concern and in full accord with its longstanding traditions, it is the sense of the Legislature to memorialize and to proclaim the week of September 21 to September 28, 2025, inclusive, as Frontotemporal Degeneration Awareness Week in California, in conjunction with the observance of World FTD Awareness Week; and
WHEREAS, The Association for Frontotemporal Degeneration (AFTD) reports that Frontotemporal Degeneration (FTD) is a terminal and incurable neurodegenerative disease affecting the frontal and temporal lobes, causing impairments to speech, personality, behavior, and motor skills that constitutes a major public health concern; and
WHEREAS, It takes an average of 3.6 years from the initial symptoms to get an accurate diagnosis of FTD, with an average life expectancy of 7 to 13 years after the initial symptoms; and
WHEREAS, FTD strikes people as young as 21 years of age and as old as 80 years of age, with the largest percentage of those affected being in their 40s to 60s, rendering people in the prime of life unable to work or function normally; and
WHEREAS, FTD imposes average annual costs associated with care and living with the disease that are approximately double those of Alzheimers disease; and
WHEREAS, FTD is identified in the National Plan to Address Alzheimers Disease as a related dementia and included as a priority in the goals and strategies of the plan to achieve the vision of a nation free of Alzheimers disease and related dementias; and
WHEREAS, The California Master Plan for Aging incorporates all 10 recommendations from the Governors Task Force on Alzheimers (Disease) Prevention and Preparedness to help people and families living with Alzheimers disease and related dementia; and
WHEREAS, FTD represents an estimated 5 to 15 percent of all dementia cases and is the most common form of dementia for people under 60 years of age; and
WHEREAS, Approximately 40 percent of people with FTD have a family history of FTD or a related condition such as Amyotrophic Lateral Sclerosis (ALS), with about one-half of those found to have an inherited form accounted for by mutations in the Progranulin, C9orf72, Tau/MAPT and other rarer genes; and
WHEREAS, FTD is often misdiagnosed as a psychiatric problem or other neurodegenerative disease because of the wide range of cognitive and behavioral symptoms and their young onset; and
WHEREAS, FTD often affects a persons ability to express emotions and to show affection and empathy for loved ones; and
WHEREAS, In the behavioral variant of FTD, a persons sense of social graces and appropriate behavior can be lost, and their personality may be significantly changed; and
WHEREAS, Furthermore, in the language variants of FTD (primary progressive aphasia), a person may have trouble producing speech and understanding grammar, lose the meaning of words or become hesitant in their speech, and may eventually become mute; and
WHEREAS, In the movement variants of FTD, a person may experience muscle weakness, falling, loss of balance, difficulty making speech, difficulty swallowing, or choking; and
WHEREAS, While there has never been a global epidemiology study of FTD, it is estimated that more than 60,000 people are affected in the United States today; and
WHEREAS, The AFTD is the leading national organization exclusively focused on the spectrum of FTD disorders with a mission to improve the quality of life of people affected by FTD and drive research to a cure; and
WHEREAS, It is imperative that there be greater awareness of this serious disease, and more must be done to increase activity at the local, state, and national levels; now, therefore, be it
Resolved by the Senate of the State of California, the Assembly thereof concurring, That the Legislature declares the week of September 21 to September 28, 2025, inclusive, as Frontotemporal Degeneration Awareness Week; and be it further
Resolved, That the Secretary of the Senate transmit copies of this resolution to the author for appropriate distribution.
WHEREAS, It is the custom of the Legislature to recognize official weeks that are set aside to increase awareness of serious health conditions that affect the lives of citizens of California; and
WHEREAS, Attendant to that concern and in full accord with its longstanding traditions, it is the sense of the Legislature to memorialize and to proclaim the week of September 21 to September 28, 2025, inclusive, as Frontotemporal Degeneration Awareness Week in California, in conjunction with the observance of World FTD Awareness Week; and
WHEREAS, The Association for Frontotemporal Degeneration (AFTD) reports that Frontotemporal Degeneration (FTD) is a terminal and incurable neurodegenerative disease affecting the frontal and temporal lobes, causing impairments to speech, personality, behavior, and motor skills that constitutes a major public health concern; and
WHEREAS, It takes an average of 3.6 years from the initial symptoms to get an accurate diagnosis of FTD, with an average life expectancy of 7 to 13 years after the initial symptoms; and
WHEREAS, FTD strikes people as young as 21 years of age and as old as 80 years of age, with the largest percentage of those affected being in their 40s to 60s, rendering people in the prime of life unable to work or function normally; and
WHEREAS, FTD imposes average annual costs associated with care and living with the disease that are approximately double those of Alzheimers disease; and
WHEREAS, FTD is identified in the National Plan to Address Alzheimers Disease as a related dementia and included as a priority in the goals and strategies of the plan to achieve the vision of a nation free of Alzheimers disease and related dementias; and
WHEREAS, The California Master Plan for Aging incorporates all 10 recommendations from the Governors Task Force on Alzheimers (Disease) Prevention and Preparedness to help people and families living with Alzheimers disease and related dementia; and
WHEREAS, FTD represents an estimated 5 to 15 percent of all dementia cases and is the most common form of dementia for people under 60 years of age; and
WHEREAS, Approximately 40 percent of people with FTD have a family history of FTD or a related condition such as Amyotrophic Lateral Sclerosis (ALS), with about one-half of those found to have an inherited form accounted for by mutations in the Progranulin, C9orf72, Tau/MAPT and other rarer genes; and
WHEREAS, FTD is often misdiagnosed as a psychiatric problem or other neurodegenerative disease because of the wide range of cognitive and behavioral symptoms and their young onset; and
WHEREAS, FTD often affects a persons ability to express emotions and to show affection and empathy for loved ones; and
WHEREAS, In the behavioral variant of FTD, a persons sense of social graces and appropriate behavior can be lost, and their personality may be significantly changed; and
WHEREAS, Furthermore, in the language variants of FTD (primary progressive aphasia), a person may have trouble producing speech and understanding grammar, lose the meaning of words or become hesitant in their speech, and may eventually become mute; and
WHEREAS, In the movement variants of FTD, a person may experience muscle weakness, falling, loss of balance, difficulty making speech, difficulty swallowing, or choking; and
WHEREAS, While there has never been a global epidemiology study of FTD, it is estimated that more than 60,000 people are affected in the United States today; and
WHEREAS, The AFTD is the leading national organization exclusively focused on the spectrum of FTD disorders with a mission to improve the quality of life of people affected by FTD and drive research to a cure; and
WHEREAS, It is imperative that there be greater awareness of this serious disease, and more must be done to increase activity at the local, state, and national levels; now, therefore, be it
Resolved by the Senate of the State of California, the Assembly thereof concurring, That the Legislature proclaims declares the week of September 21 to September 28, 2025, inclusive, as Frontotemporal Degeneration Awareness Week; and be it further
Resolved, That the Secretary of the Senate transmit copies of this resolution to the author for appropriate distribution.
WHEREAS, It is the custom of the Legislature to recognize official weeks that are set aside to increase awareness of serious health conditions that affect the lives of citizens of California; and
WHEREAS, Attendant to that concern and in full accord with its longstanding traditions, it is the sense of the Legislature to memorialize and to proclaim the week of September 21 to September 28, 2025, inclusive, as Frontotemporal Degeneration Awareness Week in California, in conjunction with the observance of World FTD Awareness Week; and
WHEREAS, The Association for Frontotemporal Degeneration (AFTD) reports that Frontotemporal Degeneration (FTD) is a terminal and incurable neurodegenerative disease affecting the frontal and temporal lobes, causing impairments to speech, personality, behavior, and motor skills that constitutes a major public health concern; and
WHEREAS, It takes an average of 3.6 years from the initial symptoms to get an accurate diagnosis of FTD, with an average life expectancy of 7 to 13 years after the initial symptoms; and
WHEREAS, FTD strikes people as young as 21 years of age and as old as 80 years of age, with the largest percentage of those affected being in their 40s to 60s, rendering people in the prime of life unable to work or function normally; and
WHEREAS, FTD imposes average annual costs associated with care and living with the disease that are approximately double those of Alzheimers disease; and
WHEREAS, FTD is identified in the National Plan to Address Alzheimers Disease as a related dementia and included as a priority in the goals and strategies of the plan to achieve the vision of a nation free of Alzheimers disease and related dementias; and
WHEREAS, The California Master Plan for Aging incorporates all 10 recommendations from the Governors Task Force on Alzheimers (Disease) Prevention and Preparedness to help people and families living with Alzheimers disease and related dementia; and
WHEREAS, FTD represents an estimated 5 to 15 percent of all dementia cases and is the most common form of dementia for people under 60 years of age; and
WHEREAS, Approximately 40 percent of people with FTD have a family history of FTD or a related condition such as ALS, Amyotrophic Lateral Sclerosis (ALS), with about one-half of those found to have an inherited form accounted for by mutations in the Progranulin, C9orf72, Tau/MAPT and other rarer genes; and
WHEREAS, FTD is often misdiagnosed as a psychiatric problem or other neurodegenerative disease because of the wide range of cognitive and behavioral symptoms and their young onset; and
WHEREAS, FTD often affects a persons ability to express emotions and to show affection and empathy for loved ones; and
WHEREAS, In the behavioral variant of FTD, a persons sense of social graces and appropriate behavior can be lost, and their personality may be significantly changed; and
WHEREAS, Furthermore, in the language variants of FTD (primary progressive aphasia), a person may have trouble producing speech and understanding grammar, lose the meaning of words or become hesitant in their speech, and may eventually become mute; and
WHEREAS, In the movement variants of FTD, a person may experience muscle weakness, falling, loss of balance, difficulty making speech, difficulty swallowing, or choking; and
WHEREAS, While there has never been a global epidemiology study of FTD, it is estimated that more than 60,000 people are affected in the United States today; and
WHEREAS, The AFTD is the leading national organization exclusively focused on the spectrum of FTD disorders with a mission to improve the quality of life of people affected by FTD and drive research to a cure; and
WHEREAS, It is imperative that there be greater awareness of this serious disease, and more must be done to increase activity at the local, state, and national levels; now, therefore, be it
Resolved by the Senate of the State of California, the Assembly thereof concurring, That the Legislature proclaims the week of September 21 to September 28, 2025, inclusive, as Frontotemporal Degeneration Awareness Week; and be it further
Resolved, That the Secretary of the Senate transmit copies of this resolution to the author for appropriate distribution.
WHEREAS, It is the custom of the Legislature to recognize official weeks that are set aside to increase awareness of serious health conditions that affect the lives of citizens of California; and
WHEREAS, Attendant to that concern and in full accord with its longstanding traditions, it is the sense of the Legislature to memorialize and to proclaim the week of September 21 to September 28, 2025, inclusive, as Frontotemporal Degeneration Awareness Week in California, in conjunction with the observance of World FTD Awareness Week; and
WHEREAS, The Association for Frontotemporal Degeneration (AFTD) reports that Frontotemporal Degeneration (FTD) is a terminal and incurable neurodegenerative disease affecting the frontal and temporal lobes, causing impairments to speech, personality, behavior, and motor skills that constitutes a major public health concern; and
WHEREAS, It takes an average of 3.6 years from the initial symptoms to get an accurate diagnosis of FTD, with an average life expectancy of 7 to 13 years after the initial symptoms; and
WHEREAS, FTD strikes people as young as 21 years of age and as old as 80 years of age, with the largest percentage of those affected being in their 40s to 60s, rendering people in the prime of life unable to work or function normally; and
WHEREAS, FTD imposes average annual costs associated with care and living with the disease that are approximately double those of Alzheimers disease; and
WHEREAS, FTD is identified in the National Plan to Address Alzheimers Disease as a related dementia and included as a priority in the goals and strategies of the plan to achieve the vision of a nation free of Alzheimers disease and related dementias; and
WHEREAS, The California Master Plan for Aging incorporates all 10 recommendations from the Governors Task Force on Alzheimers (Disease) Prevention and Preparedness to help people and families living with Alzheimers disease and related dementia; and
WHEREAS, FTD represents an estimated 5 to 15 percent of all dementia cases and is the most common form of dementia for people under 60 years of age; and
WHEREAS, Approximately 40 percent of people with FTD have a family history of FTD or a related condition such as ALS, with about one-half of those found to have an inherited form accounted for by mutations in the Progranulin, C9orf72, Tau/MAPT and other rarer genes; and
WHEREAS, FTD is often misdiagnosed as a psychiatric problem or other neurodegenerative disease because of the wide range of cognitive and behavioral symptoms and their young onset; and
WHEREAS, FTD often affects a persons ability to express emotions and to show affection and empathy for loved ones; and
WHEREAS, In the behavioral variant of FTD, a persons sense of social graces and appropriate behavior can be lost, and their personality may be significantly changed; and
WHEREAS, Furthermore, in the language variants of FTD (primary progressive aphasia), a person may have trouble producing speech and understanding grammar, lose the meaning of words or become hesitant in their speech, and may eventually become mute; and
WHEREAS, In the movement variants of FTD, a person may experience muscle weakness, falling, loss of balance, difficulty making speech, difficulty swallowing, or choking; and
WHEREAS, While there has never been a global epidemiology study of FTD, it is estimated that more than 60,000 people are affected in the United States today; and
WHEREAS, The AFTD is the leading national organization exclusively focused on the spectrum of FTD disorders with a mission to improve the quality of life of people affected by FTD and drive research to a cure; and
WHEREAS, It is imperative that there be greater awareness of this serious disease, and more must be done to increase activity at the local, state, and national levels; now, therefore, be it
Resolved by the Senate of the State of California, the Assembly thereof concurring, That the Legislature proclaims the week of September 21 to September 28, 2025, inclusive, as Frontotemporal Degeneration Awareness Week; and be it further
Resolved, That the Secretary of the Senate transmit copies of this resolution to the author for appropriate distribution.
|
Date
|
Status
|
|---|---|
| Sep 9, 2025 | Chaptered by Secretary of State. Res. Chapter 172, Statutes of 2025. |
| Sep 9, 2025 | Enrolled and filed with the Secretary of State at 11:30 a.m. |
| Sep 3, 2025 | In Senate. Ordered to engrossing and enrolling. |
| Sep 2, 2025 | Read. Adopted. (Ayes 78. Noes 0. Page 2820.) Ordered to the Senate. |
| Aug 28, 2025 | From committee: Be adopted. Ordered to consent calendar. (Ayes 9. Noes 0.) (August 28). |
| Aug 21, 2025 | Referred to Com. on RLS. |
| Aug 19, 2025 | In Assembly. Held at Desk. |
| Aug 18, 2025 | Read. Adopted. (Ayes 37. Noes 0. Page 2155.) Ordered to the Assembly. |
| Jul 9, 2025 | Read second time. Ordered to third reading. |
| Jul 8, 2025 | Ordered to second reading. |
| Jul 8, 2025 | Read third time and amended. |
| May 28, 2025 | From committee: Ordered to third reading. |
| May 20, 2025 | From committee with author's amendments. Read second time and amended. Re-referred to Com. on RLS. |
| May 15, 2025 | Introduced. Referred to Com. on RLS. |
|
Date
|
Description
|
Location
|
Votes
|
|
|---|---|---|---|---|
| Sep 2, 2025 | The committee on EDN recommend that the measure be PASSED, UNAMENDED | Assembly Floor |
Passed |
|
| Aug 28, 2025 | Be adopted. To Consent Calendar. | Assembly Standing Committee on Rules |
Passed |
|
| Aug 18, 2025 | Senate 3rd Reading SCR80 Niello et al. | Senate Floor |
Passed |
This list shows positions taken on this bill by organizations on the date displayed, which is linked to the original source.
Positions by individuals are not included.
Date of Hearing: August 28, 2025
ASSEMBLY COMMITTEE ON RULES
Blanca Pacheco, Chair
SBPCA Bill Id:SCR 80
Author:(Niello) – As Amended Ver:
SENATE VOTE:
SUBJECT: Frontotemporal Degeneration Awareness Week.
SUMMARY: Declares the week of September 21 to September 28, 2025, inclusive, as Frontotemporal Degeneration Awareness Week. Specifically, this resolution makes the following legislative findings:
- Frontotemporal Degeneration (FTD) is a terminal and incurable neurodegenerative disease affecting the frontal and temporal lobes, causing impairments to speech, personality, behavior, and motor skills that constitutes a major public health concern.
- It takes an average of 3.6 years from start of symptoms to get an accurate diagnosis of FTD with an average life expectancy of 7 to 13 years after the initial symptoms. FTD strikes people as young as 21 and as old as 80, with the largest percentage of those affected being in their 40s to 60s, rendering people in the prime of life unable to work or function normally.
- FTD imposes average annual costs associated with care and living with the disease that are approximately double those of Alzheimer’s disease.
- FTD is identified in The National Plan to Address Alzheimer’s Disease as a related dementia and is included as a priority in the goals and strategies of the Plan to achieve the vision of a nation free of Alzheimer’s disease and related dementias.
- The California Master Plan for Aging incorporates all 10 recommendations from the Governor’s Task Force on Alzheimer’s Disease Prevention and Preparedness to help people and families living with Alzheimer’s and related dementia.
- It is imperative that there be greater awareness of this serious disease, and more must be done to increase activity at the local, state, and national levels.
FISCAL EFFECT: This resolution is keyed non-fiscal by Legislative Counsel.
REGISTERED SUPPORT / OPPOSITION:
Support
None on file
Opposition
None on file
Analysis Prepared by: Michael Erke / RLS. / (916) 319-2800
SENATE RULES COMMITTEE Office of Senate Floor Analyses (916) 651-1520 Fax: (916) 327-4478 | SCR 80 |
THIRD READING
Bill No: SCR 80
Author: Niello (R), et al.
Amended: 7/8/25 in Senate
Vote: 21
SUBJECT: Frontotemporal Degeneration Awareness Week
SOURCE: Author
DIGEST:
This resolution declares the week of September 21 to September 28, 2025, inclusive, as Frontotemporal Degeneration Awareness Week.
Senate Floor Amendments of 7/8/25 add coauthors and make a technical change.
ANALYSIS: This resolution makes the following legislative findings:
- The Association for Frontotemporal Degeneration (AFTD) reports that Frontotemporal Degeneration (FTD) is a terminal and incurable neurodegenerative disease affecting the frontal and temporal lobes, causing impairments to speech, personality, behavior, and motor skills that constitutes a major public health concern.
- It takes an average of 3.6 years from the initial symptoms to get an accurate diagnosis of FTD, with an average life expectancy of 7 to 13 years after the initial symptoms. FTD strikes people as young as 21 years of age and as old as 80 years of age, with the largest percentage of those affected being in their 40s to 60s, rendering people in the prime of life unable to work or function normally.
- While there has never been a global epidemiology study of FTD, it is estimated that more than 60,000 people are affected in the United States today.
- It is imperative that there be greater awareness of this serious disease, and more must be done to increase activity at the local, state, and national levels.
This resolution declares the week of September 21 to September 28, 2025, inclusive, as Frontotemporal Degeneration Awareness Week.
Related/Prior Legislation
SCR 116 (Jones, Resolution Chapter 96, Statutes of 2024).
FISCAL EFFECT: Appropriation: No Fiscal Com.: No Local: No
SUPPORT: (Verified 7/9/25)
None received
OPPOSITION: (Verified 7/9/25)
None received
Prepared by: Hunter Flynn / SFA / (916) 651-1520
7/9/25 16:03:41
**** END ****
SENATE RULES COMMITTEE Office of Senate Floor Analyses (916) 651-1520 Fax: (916) 327-4478 | SCR 80 |
THIRD READING
Bill No: SCR 80
Author: Niello (R), et al.
Amended: 5/20/25
Vote: 21
SUBJECT: Frontotemporal Degeneration Awareness Week
SOURCE: Author
DIGEST:
This resolution proclaims the week of September 21 to September 28, 2025, inclusive, as Frontotemporal Degeneration Awareness Week.
ANALYSIS: This resolution makes the following legislative findings:
- The Association for Frontotemporal Degeneration (AFTD) reports that Frontotemporal Degeneration (FTD) is a terminal and incurable neurodegenerative disease affecting the frontal and temporal lobes, causing impairments to speech, personality, behavior, and motor skills that constitutes a major public health concern.
- It takes an average of 3.6 years from the initial symptoms to get an accurate diagnosis of FTD, with an average life expectancy of 7 to 13 years after the initial symptoms. FTD strikes people as young as 21 years of age and as old as 80 years of age, with the largest percentage of those affected being in their 40s to 60s, rendering people in the prime of life unable to work or function normally.
- While there has never been a global epidemiology study of FTD, it is estimated that more than 60,000 people are affected in the United States today.
- It is imperative that there be greater awareness of this serious disease, and more must be done to increase activity at the local, state, and national levels.
This resolution proclaims the week of September 21 to September 28, 2025, inclusive, as Frontotemporal Degeneration Awareness Week.
Related/Prior Legislation
SCR 116 (Jones, Resolution Chapter 96, Statutes of 2024)
FISCAL EFFECT: Appropriation: No Fiscal Com.: No Local: No
SUPPORT: (Verified 5/27/25)
None received
OPPOSITION: (Verified 5/27/25)
None received
Prepared by: Hunter Flynn / SFA / (916) 651-1520
5/27/25 17:45:37
**** END ****
Bill Author
Bill Co-Author(s):